This campaign has now closed
Effective treatment and eventual prevention will rely on combining a number of complex biochemical approaches. The Cure Parkinson's Trust would like to invest in some key projects in this area, particularly focusing on developing a series of pilot studies
Categories
Beneficiaries
Situation
The main treatment for Parkinson's is 40 years old. People with Parkinson's end up on complex drug regimes with their quality of life impaired by side affects. We want to see new treatments available. We have identified a lack of funding at the pilot stud
Solution
Effective treatment and eventual prevention will rely on combining a number of complex biochemical approaches such as calcium blocking drugs, inhibition of protein build-up, anti-diabetic GLP-1 therapy, growth factor delivery and anti-toxic containment of